Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Martin Wartenberg

Showing results (21-30 of 31) with videos related to

Pageof 4
Sort By:
Scientific Reports|September 29, 2023
Müller matrix polarimetry for pancreatic tissue characterizationPaulo Sampaio, Maria Lopez-Antuña, Federico Storni, et al.
European Journal of Cancer (Oxford, England : 1990)|August 1, 2016
PTEN alterations of the stromal cells characterise an aggressive subpopulation of pancreatic cancer with enhanced metastatic potentialMartin Wartenberg, Irene Centeno, Stefan Haemmig, et al.
Virchows Archiv : an International Journal of Pathology|December 17, 2020
Reproducibility of tumor budding assessment in pancreatic cancer based on a multicenter interobserver studyEva Karamitopoulou, Irene Esposito, Inti Zlobec, et al.
IEEE Transactions on Bio-Medical Engineering|February 4, 2026
Rapid, label-free cancer detection in fresh pancreatic tissue using deep learning and multispectral Mueller matrix polarimetryPaulo Sampaio, Davide Scandella, C H Lucas Patty, et al.
Science Translational Medicine|November 5, 2025
A spatial atlas of human gastrointestinal acute GVHD reveals epithelial and immune dynamics underlying disease pathophysiologyNofar Azulay, Idan Milo, Yuval Bussi, et al.
Oncogene|August 2, 2024
Normalization of Snai1-mediated vessel dysfunction increases drug response in cancerHelene Hoffmann, Martin Wartenberg, Sandra Vorlova, et al.
Journal of Gastroenterology|February 1, 2026
Agonistic GITR treatment enhances antitumor immune responses and suppresses tumor progression in pancreatic ductal adenocarcinomaSteve Robatel, Hanne Hillen, Ivanina Mutisheva, et al.
Neoplasia (New York, N.Y.)|April 20, 2021
SalvGlandDx - a comprehensive salivary gland neoplasm specific next generation sequencing panel to facilitate diagnosis and identify therapeutic targetsSandra N Freiberger, Muriel Brada, Christine Fritz, et al.
Cell Reports|March 31, 2026
Targeting PI3Kδ suppresses pancreatic cancer by dual disruption of fibrosis and immune evasionMaciej Garczyk, Gonçalo Outeiro-Pinho, Muthita Pitaktrairat, et al.
Nature Communications|January 18, 2023
Smarcd3 is an epigenetic modulator of the metabolic landscape in pancreatic ductal adenocarcinomaL Paige Ferguson, Jovylyn Gatchalian, Matthew L McDermott, et al.
Pageof 4

Showing results (21-30 of 31) with videos related to

Sort By:
Pageof 4
Scientific Reports|September 29, 2023
Müller matrix polarimetry for pancreatic tissue characterizationPaulo Sampaio, Maria Lopez-Antuña, Federico Storni, et al.
European Journal of Cancer (Oxford, England : 1990)|August 1, 2016
PTEN alterations of the stromal cells characterise an aggressive subpopulation of pancreatic cancer with enhanced metastatic potentialMartin Wartenberg, Irene Centeno, Stefan Haemmig, et al.
Virchows Archiv : an International Journal of Pathology|December 17, 2020
Reproducibility of tumor budding assessment in pancreatic cancer based on a multicenter interobserver studyEva Karamitopoulou, Irene Esposito, Inti Zlobec, et al.
IEEE Transactions on Bio-Medical Engineering|February 4, 2026
Rapid, label-free cancer detection in fresh pancreatic tissue using deep learning and multispectral Mueller matrix polarimetryPaulo Sampaio, Davide Scandella, C H Lucas Patty, et al.
Science Translational Medicine|November 5, 2025
A spatial atlas of human gastrointestinal acute GVHD reveals epithelial and immune dynamics underlying disease pathophysiologyNofar Azulay, Idan Milo, Yuval Bussi, et al.
Oncogene|August 2, 2024
Normalization of Snai1-mediated vessel dysfunction increases drug response in cancerHelene Hoffmann, Martin Wartenberg, Sandra Vorlova, et al.
Journal of Gastroenterology|February 1, 2026
Agonistic GITR treatment enhances antitumor immune responses and suppresses tumor progression in pancreatic ductal adenocarcinomaSteve Robatel, Hanne Hillen, Ivanina Mutisheva, et al.
Neoplasia (New York, N.Y.)|April 20, 2021
SalvGlandDx - a comprehensive salivary gland neoplasm specific next generation sequencing panel to facilitate diagnosis and identify therapeutic targetsSandra N Freiberger, Muriel Brada, Christine Fritz, et al.
Cell Reports|March 31, 2026
Targeting PI3Kδ suppresses pancreatic cancer by dual disruption of fibrosis and immune evasionMaciej Garczyk, Gonçalo Outeiro-Pinho, Muthita Pitaktrairat, et al.
Nature Communications|January 18, 2023
Smarcd3 is an epigenetic modulator of the metabolic landscape in pancreatic ductal adenocarcinomaL Paige Ferguson, Jovylyn Gatchalian, Matthew L McDermott, et al.
Pageof 4